Put "ZVSA" on Your Radar! (before tmrw...)

Here's why you should look into ZyVersa before tomorrow. There are a number of technical and fundamental catalysts that are worth keeping an eye on. Take a Look at "ZVSA" Hey Folks   Get ready for another exciting idea!   ZyVersa is a clinical stage specialty biopharmaceutical company with two licensed proprietary product platforms invented by top tier research scientists at University of Miami Miller School of Medicine.    The two platforms are dedicated to the treatment of inflammatory and renal diseases. Keep in mind that just the anti-inflammatory market is expected to reach $152 billion by 2033.   This means that there's plenty of growth opportunities for ZyVersa to capitalize on in their areas of expertise.   How are they planning to do this?  They currently have 5 different pharmaceutical candidates designed to tackle the anti-inflammatory market and 3 different ones for the renal disease market.   The approval of anyone of these could turn this well positioned biotech player into an overnight success story.   Though the long-term potential of biotech is compelling, the short-term catalysts are what make this sector truly electrifying!   Just take a look at ZVSA for instance... The company has over a dozen preclinical and clinical catalysts lined up, each of which have the potential to get the bulls excited.   Among these, FDA approvals stand out as the most critical milestones, as they mark pivotal moments in a drug's journey.   Each pharmaceutical candidate must navigate a rigorous, highly regulated process, with decisions made on predefined dates that can significantly impact the company's trajectory. The result?   The generation of massive hype waves that can often create strong momentum for a stock!   In the case of ZyVersa, there are three big FDA catalysts scheduled for 2025 including a pre-IND meeting, IND Filing, and phase 1 trial.   Catalysts enthusiasm might explain some of the recent price action spikes we've been seeing for ZVSA... There have been three major ones over the past few months, one of which pushed the stock to local highs of $4.33 before falling back down.   It also doesn't hurt that ZVSA has an insanely low float...   Only 2.34 million according to MarketWatch. This means that the presence of just a few bulls can turn the party into a full blown fiesta! Anyways... That's all for now!   Until Next Time, -Damian Want our text alerts? Text "ALERT" to 1-(888)-670-9763 to sign up!  (standard carrier data/text rates apply) InsiderOwl is a financial newsletter powered by ZipTrader that offers insight into the latest insider trades. This includes CEOs, CFOs, Big Money Institutions, Politicians, and More.   Terms of Service & Disclosures Found Here.  Want To Stop Receiving Emails from InsiderOwl?  Unsubscribe ZipTrader LLC 5101 SANTA MONICA BLVD STE 8 #62, 90029, LOS ANGELES, CA